CastleKeep Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
4,954
-342
-6% -$71.1K 0.59% 30
2026
Q1
$1.12M Sell
5,296
-1,170
-18% -$252K 0.61% 32
2025
Q4
$1.33M Sell
6,466
-55
-0.8% -$10.4K 0.6% 47
2025
Q3
$1.02M Sell
6,521
-2,626
-29% -$406K 0.48% 55
2025
Q2
$1.54M Sell
9,147
-792
-8% -$118K 0.75% 32
2025
Q1
$1.37M Sell
9,939
-693
-7% -$88.3K 0.7% 41
2024
Q4
$1.26M Sell
10,632
-10,531
-50% -$1.23M 0.88% 39
2024
Q3
$2.34M Buy
21,163
+1,655
+8% +$173K 1.6% 11
2024
Q2
$1.92M Buy
19,508
+2,843
+17% +$290K 1.48% 11
2024
Q1
$1.86M Sell
16,665
-3,968
-19% -$428K 1.34% 13
2023
Q4
$2.08M Buy
+20,633
New +$2.05M 1.48% 13

Other funds holding CAH

CastleKeep Investment Advisors's CAH Position: Q2 2026 in Review

CastleKeep Investment Advisors reduced its Cardinal Health (CAH) stake by 6.5% in Q2 2026, selling an estimated $71.1K and leaving 4,954 shares worth $1.18M. The position accounts for 0.59% of the portfolio, ranked #30.

CastleKeep Investment Advisors first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.34M in Q3 2024. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • CastleKeep Investment Advisors held 4,954 shares of Cardinal Health worth $1.18M as of Q2 2026.
  • CastleKeep Investment Advisors sold 342 Cardinal Health shares in Q2 2026, an estimated $71.1K.
  • Cardinal Health made up 0.59% of CastleKeep Investment Advisors's portfolio in Q2 2026, its #30 holding.
  • CastleKeep Investment Advisors first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • CastleKeep Investment Advisors's Cardinal Health position peaked at $2.34M in Q3 2024.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on CastleKeep Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.